-
Publication Venue For
-
Chondroprotection of leptin deficiency demystified?.
31:18-20.
2023
-
In vivo intervertebral disc mechanical deformation following a treadmill walking "stress test" is inversely related to T1rho relaxation time..
31:126-133.
2023
-
Clinical monitoring in osteoarthritis: Biomarkers..
30:1159-1173.
2022
-
Single cell transcriptomics in human osteoarthritis synovium and in silico deconvoluted bulk RNA sequencing..
30:475-480.
2022
-
Epidemiology of osteoarthritis..
30:184-195.
2022
-
Immune cell profiling in the joint following human and murine articular fracture..
29:915-923.
2021
-
Blood in the joint: effects of hemarthrosis on meniscus health and repair techniques..
29:471-479.
2021
-
Cost-effectiveness of physical activity and exercise therapy programs for knee osteoarthritis: making the case for health plan coverage..
28:719-720.
2020
-
Anti-inflammatory effects of naproxen sodium on human osteoarthritis synovial fluid immune cells..
28:639-645.
2020
-
Intra-articular depletion of macrophages increases acute synovitis and alters macrophage polarity in the injured mouse knee..
28:626-638.
2020
-
Development of a core capability framework for qualified health professionals to optimise care for people with osteoarthritis: an OARSI initiative..
28:154-166.
2020
-
Infrapatellar fat pad abnormalities are associated with a higher inflammatory synovial fluid cytokine profile in young adults following ACL tear..
28:82-91.
2020
-
OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis..
27:1578-1589.
2019
-
Ninety-day and one-year healthcare utilization and costs after knee arthroplasty..
27:1462-1469.
2019
-
Priorities for the effective implementation of osteoarthritis management programs: an OARSI international consensus exercise..
27:1270-1279.
2019
-
Model-based pain and function outcome trajectory types for patients undergoing knee arthroplasty: a secondary analysis from a randomized clinical trial..
27:878-884.
2019
-
Proposed study designs for approval based on a surrogate endpoint and a post-marketing confirmatory study under FDA's accelerated approval regulations for disease modifying osteoarthritis drugs..
27:571-579.
2019
-
Osteoarthritis year in review 2018: mechanics..
27:392-400.
2019
-
Towards prevention of post-traumatic osteoarthritis: report from an international expert working group on considerations for the design and conduct of interventional studies following acute knee injury..
27:23-33.
2019
-
Biomarkers of inflammation - LBP and TLR- predict progression of knee osteoarthritis in the DOXY clinical trial..
26:1658-1665.
2018
-
Associations between the chemokine biomarker CCL2 and knee osteoarthritis outcomes: the Johnston County Osteoarthritis Project..
26:1257-1261.
2018
-
Colchicine lack of effectiveness in symptom and inflammation modification in knee osteoarthritis (COLKOA): a randomized controlled trial..
26:631-640.
2018
-
Physical therapy vs internet-based exercise training for patients with knee osteoarthritis: results of a randomized controlled trial..
26:383-396.
2018
-
Synovial fluid pro-inflammatory profile differs according to the characteristics of knee pain..
25:1420-1427.
2017
-
Pain prediction by serum biomarkers of bone turnover in people with knee osteoarthritis: an observational study of TRAcP5b and cathepsin K in OA..
25:858-865.
2017
-
Reply to Stausholm et al.'s letter to the editor regarding our published study entitled, "Effectiveness of low-level laser therapy in patients with knee osteoarthritis: a systematic review and meta-analysis"..
25:e11-e14.
2017
-
Chondroitin sulphate inhibits NF-κB activity induced by interaction of pathogenic and damage associated molecules..
25:166-174.
2017
-
Disease-modifying treatments for osteoarthritis (DMOADs) of the knee and hip: lessons learned from failures and opportunities for the future..
24:2013-2021.
2016
-
Both systemic and local lipopolysaccharide (LPS) burden are associated with knee OA severity and inflammation..
24:1769-1775.
2016
-
Clinical algorithms to aid osteoarthritis guideline dissemination..
24:1487-1499.
2016
-
Exploratory secondary analyses of a cognitive-behavioral intervention for knee osteoarthritis demonstrate reduction in biomarkers of adipocyte inflammation..
24:1528-1534.
2016
-
Advances in combining gene therapy with cell and tissue engineering-based approaches to enhance healing of the meniscus..
24:1330-1339.
2016
-
Notch signaling in postnatal joint chondrocytes, but not subchondral osteoblasts, is required for articular cartilage and joint maintenance..
24:740-751.
2016
-
Aspartic acid racemization reveals a high turnover state in knee compared with hip osteoarthritic cartilage..
24:374-381.
2016
-
Atlas of radiographic features of osteoarthritis of the ankle and hindfoot..
23:2059-2085.
2015
-
Inflammatory biomarkers in osteoarthritis..
23:1890-1896.
2015
-
Plasma levels of interleukin-1 receptor antagonist (IL1Ra) predict radiographic progression of symptomatic knee osteoarthritis..
23:1915-1924.
2015
-
KOOS pain as a marker for significant knee pain two and six years after primary ACL reconstruction: a Multicenter Orthopaedic Outcomes Network (MOON) prospective longitudinal cohort study..
23:1674-1684.
2015
-
Non-invasive mouse models of post-traumatic osteoarthritis..
23:1627-1638.
2015
-
Effectiveness of low-level laser therapy in patients with knee osteoarthritis: a systematic review and meta-analysis..
23:1437-1444.
2015
-
Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use..
23:1233-1241.
2015
-
Radiographic features of hand osteoarthritis in adult Kashin-Beck Disease (KBD): the Yongshou KBD study..
23:868-873.
2015
-
OARSI Clinical Trials Recommendations: Design and conduct of clinical trials for hand osteoarthritis..
23:772-786.
2015
-
OARSI Clinical Trials Recommendations: Design and conduct of clinical trials of lifestyle diet and exercise interventions for osteoarthritis..
23:787-797.
2015
-
OARSI Clinical Trials Recommendations: Design and conduct of implementation trials of interventions for osteoarthritis..
23:826-838.
2015
-
OARSI Clinical Trials Recommendations: Soluble biomarker assessments in clinical trials in osteoarthritis..
23:686-697.
2015
-
Insights into osteoarthritis progression revealed by analyses of both knee tibiofemoral compartments..
23:571-580.
2015
-
OA phenotypes, rather than disease stage, drive structural progression--identification of structural progressors from 2 phase III randomized clinical studies with symptomatic knee OA..
23:550-558.
2015
-
Retinal arteriolar narrowing and incidence of knee replacement for osteoarthritis: a prospective cohort study..
23:589-593.
2015
-
Knee osteoarthritis radiographic progression and associations with pain and function prior to knee arthroplasty: a multicenter comparative cohort study..
23:391-396.
2015
-
Hyaluronan molecular weight distribution is associated with the risk of knee osteoarthritis progression..
23:70-76.
2015
-
Energy recovery in individuals with knee osteoarthritis..
22:747-755.
2014
-
TSG-6 activity as a novel biomarker of progression in knee osteoarthritis..
22:235-241.
2014
-
Osteoarthritis--a case for personalized health care?.
22:7-16.
2014
-
High prevalence of contralateral ankle abnormalities in association with knee osteoarthritis and malalignment..
21:1693-1699.
2013
-
Imaging biomarker validation and qualification report: sixth OARSI Workshop on Imaging in Osteoarthritis combined with third OA Biomarkers Workshop..
21:939-942.
2013
-
Direct assessment of articular cartilage and underlying subchondral bone reveals a progressive gene expression change in human osteoarthritic knees..
21:450-461.
2013
-
A discrete-choice experiment of United Kingdom patients' willingness to risk adverse events for improved function and pain control in osteoarthritis..
21:289-297.
2013
-
Association between serum and urine biomarkers and lumbar spine individual radiographic features: the Johnston County Osteoarthritis Project..
20:1286-1293.
2012
-
Osteoarthritis and the metabolic syndrome: more evidence that the etiology of OA is different in men and women..
20:603-604.
2012
-
DIO2 modifies inflammatory responses in chondrocytes..
20:440-445.
2012
-
Effects of intraarticular IL1-Ra for acute anterior cruciate ligament knee injury: a randomized controlled pilot trial (NCT00332254)..
20:271-278.
2012
-
Global metabolic profiling of human osteoarthritic synovium..
20:64-67.
2012
-
Coronal plane ankle alignment, gait, and end-stage ankle osteoarthritis..
19:1338-1342.
2011
-
Summary of the OA biomarkers workshop 2010 - genetics and genomics: new targets in OA..
19:1091-1094.
2011
-
Acute joint pathology and synovial inflammation is associated with increased intra-articular fracture severity in the mouse knee..
19:864-873.
2011
-
Association of knee and ankle osteoarthritis with physical performance..
19:634-638.
2011
-
Subchondral bone remodeling is related to clinical improvement after joint distraction in the treatment of ankle osteoarthritis..
19:668-675.
2011
-
Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis..
19:515-542.
2011
-
Recommendations of the OARSI FDA Osteoarthritis Devices Working Group..
19:509-514.
2011
-
Osteoarthritis year 2010 in review: biochemical markers..
19:346-353.
2011
-
Selenomethionine inhibits IL-1β inducible nitric oxide synthase (iNOS) and cyclooxygenase 2 (COX2) expression in primary human chondrocytes..
19:118-125.
2011
-
Basic methods in histopathology of joint tissues..
18 Suppl 3:S113-S116.
2010
-
Histopathology atlas of animal model systems - overview of guiding principles..
18 Suppl 3:S2-S6.
2010
-
The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the guinea pig..
18 Suppl 3:S35-S52.
2010
-
Dynamic loading enhances integrative meniscal repair in the presence of interleukin-1..
18:830-838.
2010
-
Serum transforming growth factor-beta 1 is not a robust biomarker of incident and progressive radiographic osteoarthritis at the hip and knee: the Johnston County Osteoarthritis Project..
18:825-829.
2010
-
Summary of the OA biomarkers workshop 2009--biochemical biomarkers: biology, validation, and clinical studies..
18:742-745.
2010
-
Collagen fibril disruption occurs early in primary guinea pig knee osteoarthritis..
18:397-405.
2010
-
A comparison of five approaches to measurement of anatomic knee alignment from radiographs..
18:273-277.
2010
-
Racial differences in osteoarthritis pain and function: potential explanatory factors..
18:160-167.
2010
-
Daily pain variations among patients with hand, hip, and knee osteoarthritis..
17:1275-1282.
2009
-
Racial differences in self-reported pain and function among individuals with radiographic hip and knee osteoarthritis: the Johnston County Osteoarthritis Project..
17:1132-1136.
2009
-
Subregional femorotibial cartilage morphology in women--comparison between healthy controls and participants with different grades of radiographic knee osteoarthritis..
17:1177-1185.
2009
-
Transglutaminase 2 is a marker of chondrocyte hypertrophy and osteoarthritis severity in the Hartley guinea pig model of knee OA..
17:1056-1064.
2009
-
Failure of serum transforming growth factor-beta (TGF-beta1) as a biomarker of radiographic osteoarthritis at the knee and hip: a cross-sectional analysis in the Johnston County Osteoarthritis Project..
17:772-776.
2009
-
Symptoms of the knee and hip in individuals with and without limb length inequality..
17:596-600.
2009
-
Novel synovial fluid recovery method allows for quantification of a marker of arthritis in mice..
16:1532-1538.
2008
-
Performance of a non-fluoroscopically assisted substitute for the Lyon schuss knee radiograph: quality and reproducibility of positioning and sensitivity to joint space narrowing in osteoarthritic knees..
16:1555-1559.
2008
-
Re: Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008;16:137-62..
16:1585.
2008
-
Absence of association of asporin polymorphisms and osteoarthritis susceptibility in US Caucasians..
16:1174-1177.
2008
-
PIIANP and HELIXII diurnal variation..
16:1192-1195.
2008
-
Biomarkers associated with clinical phenotypes of hand osteoarthritis in a large multigenerational family: the CARRIAGE family study..
16:1054-1059.
2008
-
IN VIVO STRAIN INCREASES FOLLOWING MEDIAL MENISCAL TEAR AND CORRELATES WITH SYNOVIAL FLUID MATRIX METALLOPROTEINASE ACTIVITY
-
Alpha defensin-1 attenuates surgically induced osteoarthritis in association with promoting M1 to M2 macrophage polarization.
2021
-
TSG-6 - a double-edged sword for osteoarthritis (OA).
2018
-
Synovial and systemic pharmacokinetics (PK) of triamcinolone acetonide (TA) following intra-articular (IA) injection of an extended-release microsphere-based formulation (FX006) or standard crystalline suspension in patients with knee osteoarthritis (OA).
2018
-
Biomarkers reflect differences in osteoarthritis phenotypes of the lumbar spine: the Johnston County Osteoarthritis Project.
2017
-
Direct in vivo evidence of activated macrophages in human osteoarthritis.
2016